icon-folder.gif   Conference Reports for NATAP  
 
  64rd Annual Meeting of the
American Association for the
Study of Liver Diseases
Washington, DC Nov 1-5 2013
Back grey_arrow_rt.gif
 
 
 
Pretransplant Sofosbuvir and Ribavirin to
Prevent Recurrence of HCV Infection After Liver Transplantation

 
 
  Reported by Jules Levin
AASLD 2013 Nov 1-4 Wash DC
 
Michael P. Curry1, Xavier Forns2, Raymond Chung3, Norah Terrault4, Robert Brown Jr5, Jonathan M. Fenkel6, Fredric Gordon7, Jacqueline O'Leary8, Alexander Kuo9, Thomas Schiano10, Gregory Everson11, Eugene Schiff12, Alex Befeler13, John G. McHutchison14, William T. Symonds14, Jill Denning14, Lindsay McNair14, Sarah Arterburn14, Dilip Moonka15 Edward Gane16, Nezam Afdhal1
1Beth Israel Deaconess Medical Center, Boston, MA; 2The Liver Unit, Barcelona, Spain; 3Massachusetts General Hospital, Boston, MA; 4University of California, San Francisco, CA; 5Columbia University, New York, NY; 6Thomas Jefferson University Hospital, Philadelphia, PA; 7Lahey Clinic, Burlington, MA; 8Baylor University Medical Center,, Dallas, TX; 9University of California, San Diego, La Jolla, CA; 10Mount Sinai School of Medicine, New York, NY; 11University of Colorado, Denver, CO; 12University of Miami, Miami, FL; 13St Louis University, St. Louis, MO; 14Gilead Sciences, Inc., Foster City, CA; 15Henry Ford Health System, Detroit, MI; 16Auckland City Hospital, Auckland, New Zealand

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif

AASLD12.gif